“…Likewise, serum levels of proinflammatory interleukins IL-1b, IL-6, and TNF-a are elevated in depressed patients (Maes, 1999;Tuglu et al, 2003). Conversely, therapeutic treatments with proinflammatory cytokines result in 'sickness behavior' that is similar in many respects to depression, with decreased appetite, anorexia, weight loss, fatigue, loss of libido, sleep disturbances, and reduced social contact (Kent et al, 1996;Yirmiya et al, 2000;Dantzer, 2001), and depression is frequently observed in association with peripheral inflammatory cytokine activation in a number of medical conditions including viral infections, rheumatoid arthritis, cancer, and neurodegenerative diseases (Meijer et al, 1988;Hall and Smith, 1996;Yirmiya et al, 1999;Pollak et al, 2000). Additionally, in human volunteers, depression, anxiety, and memory impairment are associated with immune activation by the bacterial endotoxin, lipopolysaccharide, and are correlated with serum IL-1b and TNF-a levels induced by that treatment (Yirmiya et al, 2000).…”